Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN)

CUSIP: 59045L106

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
4,992,318
Total 13F shares
117,492,700
Share change
+4,360,096
Total reported value
$526,342,513
Put/Call ratio
205%
Price per share
$4.48
Number of holders
124
Value change
+$23,958,185
Number of buys
69
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 59045L106?
CUSIP 59045L106 identifies MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q1 2024

As of 31 Mar 2024, Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by 124 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 117,492,700 shares. The largest 10 holders included EcoR1 Capital, LLC, VR Adviser, LLC, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Nextech Invest Ltd., Balyasny Asset Management L.P., CITADEL ADVISORS LLC, and Rock Springs Capital Management LP. This page lists 124 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.